Silver Book Fact

Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.

Xu, Zheng-Zhong, Ling Zhang, Tong Liu, John Yeon Park, Temugin Berta, Rong Yang, Charles N Sherhand, and Ru-Rong Ji. Resolvins RvE1 and RvD1 Attenuate Inflammatory Pain Via Central and Peripheral Actions. Nature Med. 2010; 16(5): 592-7. http://www.nature.com/nm/journal/v16/n5/full/nm.2123.html

Reference

Title
Resolvins RvE1 and RvD1 Attenuate Inflammatory Pain Via Central and Peripheral Actions
Publication
Nature Med
Publication Date
2010
Authors
Xu, Zheng-Zhong, Ling Zhang, Tong Liu, John Yeon Park, Temugin Berta, Rong Yang, Charles N Sherhand, and Ru-Rong Ji
Volume & Issue
Volume 16, Issue 5
Pages
592-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Targeting A-type K+ channels in primary sensory neurons could provide a novel mechanism-based therapy for the treatment of bone cancer pain–one of the most severe types of chronic pain.  
  • Topical capsaicin was found in a meta-analysis to provide a degree of pain relief to some patients with painful neuropathic conditions.  
  • Antiepileptic drugs relieve persistent neuropathic pain. One meta-analysis found gabapentin to be associated with moderate benefit (equivalent to 30% pain relief) in close to 1 in 2 patients, and…  
  • A biopsychosocial approach (i.e., one that takes into account physical, emotional, and environmental factors in the assessment and treatment of pain) has been found to improve the pain care of…  
  • Researchers have developed several sub-types of ion channels that allow inflammation and growth factors to trigger persistent pain.